Refine your search

Your search returned 3 results.

Sort
Results
1.
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. MedStar authors:
  • Carrasquilla, Michael
PMID:
  • 36826994
Year: 2023
Citation:
  • Acta Oncologica. :1-6, 2023 Feb 24
Department:
  • MedStar Georgetown University Hospital/MedStar Washington Hospital Center
  • Radiation Oncology Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Repka MC, Carrasquilla M, Paydar I, Wu B, Lei S, Suy S, Collins SP, Kole TP
2.
Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy. MedStar authors:
  • Carrasquilla, Michael
PMID:
  • 35096594
Year: 2021
Citation:
  • Frontiers in Oncology. 11:794615, 2021.
Department:
  • MedStar Georgetown University Hospital/MedStar Washington Hospital Center
  • Radiation Oncology Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Anaizi AN, Atkins MB, Burke AM, Carrasquilla M, Collins BT, Collins SP, Gibney GT, Jean WC
3.
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer. [Review] MedStar authors:
  • Carrasquilla, Michael
PMID:
  • 35433457
Year: 2022
Citation:
  • Frontiers in Oncology. 12:860848, 2022.
Department:
  • MedStar Georgetown University Hospital/MedStar Washington Hospital Center
  • Radiation Oncology Residency
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aghdam N, Carrasquilla M, Collins BT, Collins SP, Creswell M, Forsthoefel M, Hankins RA, Kataria S, Lee J, Lei S, Lischalk JW, Obayomi-Davies O, Repka MC, Suy S
Pages

Powered by Koha